Log in to save to my catalogue

Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired...

Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04385796v1

Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signaling

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Phospholipase A/acyltransferase 3 (PLAAT3) is a phospholipid-modifying enzyme predominantly expressed in neural and white adipose tissue (WAT). It is a potential drug target for metabolic syndrome, as
Plaat3
deficiency in mice protects against diet-induced obesity. We identified seven patients from four unrelated consanguineous families, with...

Alternative Titles

Full title

Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04385796v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04385796v1

Other Identifiers

ISSN

1061-4036

E-ISSN

1546-1718

DOI

10.1038/s41588-023-01535-3

How to access this item